Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas<i>In vitro</i>and<i>In vivo</i>
Shuang Yan(Cancer Institute (WIA)), Carol J. Thiele(Pediatric Oncology Group)
Cited by 94
Related Papers
MYCN and the epigenome
|Frontiers in Oncology|2013|329
Essential Role of the Zinc Finger Transcription Factor Casz1 for Mammalian Cardiac Morphogenesis and Development
|Journal of Biological Chemistry|2014|74
Genetic and Pharmacologic Identification of Akt as a Mediator of Brain-Derived Neurotrophic Factor/TrkB Rescue of Neuroblastoma Cells from Chemotherapy-Induced Cell Death
|Cancer Research|2005|69
ZGRF1 promotes end resection of DNA homologous recombination via forming complex with BRCA1/EXO1
|Cell Death Discovery|2021|12